http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ecbf51348d2a4aca28241313562a3eae
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hatjiharissi |
| name | Evdoxia Hatjiharissi |
| given-name | Evdoxia |
| organization-name | Dana-Farber Cancer Institute, Boston, MA;; Harvard Medical School, Boston, MA; 2Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts; Department of Hematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece; Hematology Unit, 1st Dept of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; From the Dana-Farber Cancer Institute, Boston, MA; the Veteran's Administration (VA) Boston Healthcare System, Boston, MA; the Brigham and Woman's Hospital, Harvard Medical School, Boston, MA; and the University of Magna Græcia and Cancer Center, Catanzaro, Italy. From the Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; and Service des maladies du sang, Hopital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France First Department of Internal Medicine, Division of Haematology, AHEPA University Hospital Aristotle University of Thessaloniki Thessaloniki Greece First Department of Internal Medicine, Division of Hematology AHEPA University Hospital, Aristotle University of Thessaloniki, School of Medicine Thessaloniki Greece Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Hematology, Theageneion Hospital of Thessaloniki, Thessaloniki, Greece. Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute,; Harvard Medical School, and Department of Haematology, Theagenio Cancer Hospital, Thessaloniki, Greece; Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;; Harvard Medical School, Boston, MA; From the Department of Hematology, Faculty of Medicine Imperial College, Hammersmith Hospital, London, United Kingdom; the Department of Hematology, Theagenion Cancer Center, Thessaloniki, Greece; and the First Department of Medicine, University of Athens School of Medicine, Laikon Hospital, Greece Department of Pathology Boston University Medical Center Boston MA USA; Theagenio Cancer Hospital Thessaloniki Greece Department of Haematology Theageneion Hospital of Thessaloniki Thessaloniki Greece Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; 2Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Department of Hematology “Theagenio” Cancer Center Thesasloniki, Greece Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA;; Harvard Medical School, Boston, MA;; School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece; 1Bing Center for Waldenström's Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts; |
Incoming Links
Total number of triples: 79.